Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: Comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma

Daniel N. Dang, Ganesh Raj, Venetia Sarode, Kyle H. Molberg, Ratna K. Vadlamudi, Yan Peng

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

PELP1 is a novel coregulator of nuclear hormone receptors and is implicated in playing a role in driving breast cancer and enhancing metastatic potential. The PELP1 protein expression and potential role of PELP1 in triple-negative breast carcinoma (TNBC) have not been well characterized. We investigated PELP1 expression by immunohistochemistry in primary and metastatic triple-negative tumors in human tissues and compared its expression with GATA-binding protein 3 (GATA3), a novel diagnostic marker for TNBC. We examined the expression of PELP1 and GATA3 in 70 primary TNBC cases and found that PELP1 had a significantly higher frequency of expression compared to GATA3 (96% versus 46%; P

Original languageEnglish (US)
Pages (from-to)1829-1835
Number of pages7
JournalHuman Pathology
Volume46
Issue number12
DOIs
StatePublished - Dec 1 2015

Fingerprint

Carrier Proteins
Breast Neoplasms
Proteins
Cytoplasmic and Nuclear Receptors
Immunohistochemistry
Neoplasms

Keywords

  • GATA3
  • Immunohistochemistry
  • Metastasis
  • PELP1
  • Triple-negative breast carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

@article{f4881972efa845bc92c8e2baf7ef9384,
title = "Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: Comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma",
abstract = "PELP1 is a novel coregulator of nuclear hormone receptors and is implicated in playing a role in driving breast cancer and enhancing metastatic potential. The PELP1 protein expression and potential role of PELP1 in triple-negative breast carcinoma (TNBC) have not been well characterized. We investigated PELP1 expression by immunohistochemistry in primary and metastatic triple-negative tumors in human tissues and compared its expression with GATA-binding protein 3 (GATA3), a novel diagnostic marker for TNBC. We examined the expression of PELP1 and GATA3 in 70 primary TNBC cases and found that PELP1 had a significantly higher frequency of expression compared to GATA3 (96{\%} versus 46{\%}; P",
keywords = "GATA3, Immunohistochemistry, Metastasis, PELP1, Triple-negative breast carcinoma",
author = "Dang, {Daniel N.} and Ganesh Raj and Venetia Sarode and Molberg, {Kyle H.} and Vadlamudi, {Ratna K.} and Yan Peng",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.humpath.2015.07.023",
language = "English (US)",
volume = "46",
pages = "1829--1835",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "12",

}

TY - JOUR

T1 - Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma

T2 - Comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma

AU - Dang, Daniel N.

AU - Raj, Ganesh

AU - Sarode, Venetia

AU - Molberg, Kyle H.

AU - Vadlamudi, Ratna K.

AU - Peng, Yan

PY - 2015/12/1

Y1 - 2015/12/1

N2 - PELP1 is a novel coregulator of nuclear hormone receptors and is implicated in playing a role in driving breast cancer and enhancing metastatic potential. The PELP1 protein expression and potential role of PELP1 in triple-negative breast carcinoma (TNBC) have not been well characterized. We investigated PELP1 expression by immunohistochemistry in primary and metastatic triple-negative tumors in human tissues and compared its expression with GATA-binding protein 3 (GATA3), a novel diagnostic marker for TNBC. We examined the expression of PELP1 and GATA3 in 70 primary TNBC cases and found that PELP1 had a significantly higher frequency of expression compared to GATA3 (96% versus 46%; P

AB - PELP1 is a novel coregulator of nuclear hormone receptors and is implicated in playing a role in driving breast cancer and enhancing metastatic potential. The PELP1 protein expression and potential role of PELP1 in triple-negative breast carcinoma (TNBC) have not been well characterized. We investigated PELP1 expression by immunohistochemistry in primary and metastatic triple-negative tumors in human tissues and compared its expression with GATA-binding protein 3 (GATA3), a novel diagnostic marker for TNBC. We examined the expression of PELP1 and GATA3 in 70 primary TNBC cases and found that PELP1 had a significantly higher frequency of expression compared to GATA3 (96% versus 46%; P

KW - GATA3

KW - Immunohistochemistry

KW - Metastasis

KW - PELP1

KW - Triple-negative breast carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84947210605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947210605&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2015.07.023

DO - 10.1016/j.humpath.2015.07.023

M3 - Article

C2 - 26428280

AN - SCOPUS:84947210605

VL - 46

SP - 1829

EP - 1835

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 12

ER -